NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION (INCLUDING THE UNITED STATES) WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.
14 December 2020
Sativa Wellness Group Inc.
(“Sativa Wellness” or the “Company”)
SATIVA QUALIFIES FOR NEW APEX MARKET SEGMENT
Sativa Wellness (AQSE and CSE: SWEL) notes today’s announcement by the Aquis Stock Exchange PLC, that the two new segments of the market have come into force. Please see Aquis Stock Exchange link for the full announcement.
Sativa Wellness has been notified by AQSE that it qualifies for the “Apex” segment of the AQSE Growth Market. In order to be eligible for admission to Apex, Sativa has succeeded in meeting, amongst other things, the following eligibility criteria:
• A minimum market capitalisation of £10 million
• At least 25% shares in public hands
• At least 2 market makers
• A minimum 2 years’ trading history
• Adopted a recognised governance code
In meeting the above criteria, the Company expects that there will be more retail and institutional interest, leading to higher trading volumes, and an enhanced ability to use its APEX segment public market status to raise money.
Henry Lees-Buckley, CEO of the Sativa Wellness Group Inc. stated “the status of the Apex segment is clearly designed for more established companies that have experienced boards and corporate governance standards. We welcome this segmentation from the Aquis Stock Exchange, and believe that the Apex segment is better placed to support our growth ambitions”.
The Directors of the Company accept responsibility for the contents of this announcement.
On behalf of the Board of Directors,